Epstein Secrets

arry flow through rate is calculated as the net realized carry tor the period as a % of the BOP net performance fee gainfirecewable balance. Source. Company Data. Morgan Stanley Research Exhibit 4: Net Performance Fee Receivable Balance Per Share Roll Forward Net Performance Fee (Carry) Receivable Balance Ro

meStCeS decision to buy or sell a stock should depend on inthidual circumstances (such as the iniesta% existing hddings) and either considerations. Global Stock Ratings Distribution (as cf Mach 31. 2015) For disclosure purposes only (in accordance wth NASD and NYSE requirements). we include the category heeings of Buy, Held, at

14 14 Total Rev nu 7,011 7,949 8,385 9,703 11,203 4,999 6,535 5,867 7.716 25,178 28,174 29.670 27,166 25.703 23.366 23,109 Smote: Company Data. 1.5angan Stanley Research EFTA00598627 Morgan Stanley MORGAN STANLEY RESEARCH July 23. 2014 Gilead Sciences Inc. Exhite 6 Gilead Balance She

or's decision to buy or sell a stock should depend on individual circumstances (such as the investor's existing holdings) and other considerations. Global Stock Ratings Distribution (as of June 30. 2014) For disclosure purposes only (in accordance with NASD and NYSE requirements). we include the category headings of Buy. Hold.

57 44 78 52 22 15 Ii 103 105 110 116 122 128 134 otal Revenues 2.130 2.421 2.468 2.606 4 10.66$ 11.866 12.870 14.495 Soiree. Company Data. Morgan Stanley Research EFTA00598611 Morgan Stanley MORGAN STANLEY RESEARCH July 23. 2014 Biogen Idec Inc. Exhibit Biogen Idec Balance Sheet

or's decision to buy or sell a stock should depend on individual circumstances (such as the investor's existing holdings) and other considerations. Global Stock Ratings Distribution (as of June 30. 2014) For disclosure purposes only (in accordance with NASD and NYSE requirements). we include the category headings of Buy. Hold.